Lithium

Lithium

SCHEMBL7657786

CSCCC(NC(=O)CN1C(=O)N(CCCc2cncn2Cc2ccc(C#N)cc2)C(=O)C1(C)c1cccc2ccccc12)C(=O)O.[Li]

nearest known ligand 0.66

Full drug profile on Sugi Atlas →

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
FNTA P49354 20/20 0.66
FNTB P49356 20/20 0.66

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7655399 0.99 FNTA (0.66) FNTAFNTB
SCHEMBL7657766 0.99 FNTA (0.66) FNTAFNTB
Lithium Ion SCHEMBL7657776 0.94 FNTA (0.60) FNTAFNTB
SCHEMBL7656712 0.94 FNTA (0.67) FNTAFNTB
SCHEMBL7657699 0.93 FNTA (0.66) FNTAFNTB
Lithium SCHEMBL7653538 0.87 FNTA (0.59) FNTAFNTB
SCHEMBL7655415 0.87 FNTA (0.66) FNTAFNTB
SCHEMBL7661055 0.86 FNTA (0.60) FNTAFNTB
SCHEMBL7653525 0.85 FNTA (0.59) FNTAFNTB
Lithium Ion SCHEMBL7653530 0.83 FNTA (0.58) FNTAFNTB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6384061-B1 HYDANTOIN COMPOUNDS REPRESENTED BY FORMULA (I) WHICH SHOWS AN INHIBITORY ACTIVITY AGAINST FARNESYL TRANSFERASE, AND THUS CAN BE USED AS AN ANTI-CANCER AGENT, OR PHARMACEUTICALLY ACCEPTABLE SALTS LG CHEMICAL LTD. (KR) 2002-05-07 US disclosed
EP-1000036-A1 HYDANTOIN DERIVATIVES HAVING AN INHIBITORY ACTIVITY FOR FARNESYL TRANSFERASE LG CHEMICAL LIMITED (KR) 2000-05-17 EP disclosed
WO-1999005117-A1 HYDANTOIN DERIVATIVES HAVING AN INHIBITORY ACTIVITY FOR FARNESYL TRANSFERASE LG CHEMICAL LTD. (KR) 1999-02-04 WO disclosed